Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 10, Number 5—May 2004

Research

Clinical Manifestations, Laboratory Findings, and Treatment Outcomes of SARS Patients

Jann-Tay Wang*, Wang-Huei Sheng*, Chi-Tai Fang*, Yee-Chun Chen*, Jiun-Ling Wang*, Chong-Jen Yu*, Shan-Chwen Chang*Comments to Author , and Pan-Chyr Yang*
Author affiliations: *National Taiwan University Hospital, Taipei, Taiwan

Main Article

Table 1

Demographic data and initial clinical signs and symptoms of 76 patients with probable SARSa

Data No. of cases (%)
Sex

   Male
34 (44.7)
   Female
42 (55.3)
Age (y) (range, median)
24–87 (46.5)
Underlying disease (no.)

Nonfatal
62 (81.6)
No underlying disease
52 (68.4)
Mild underlying disease
10 (13.2)
Ultimately fatal
3 (3.9)
Rapidly fatal
11 (14.5)
Initial symptoms

Fever
76 (100)
     Cough
47 (61.8)
     Myalgia
37 (48.7)
     Dyspnea
31 (40.8)
     Diarrhea
24 (31.6)
     Rigor
23 (30.3)
     Headache
14 (18.4)
     Nausea
9 (11.8)
     Sore throat
7 (9.2)
     Vomiting
3 (3.9)
     Rhinorrhea 2 (2.6)

aSARS, severe acute respiratory syndrome.

Main Article

TOP